Breaking News Instant updates and real-time market news.

DXCM

DexCom

$58.08

0.09 (0.16%)

, ABT

Abbott

$59.19

0.27 (0.46%)

11:22
01/04/18
01/04
11:22
01/04/18
11:22

Dexcom to Underperform at Northland

As previously reported, Northland analyst Suraj Kalia downgraded Dexcom (DXCM) to Underperform from Market Perform after Abbott (ABT) announced Medicare coverage for its Libre FGM. The analyst believes it undercuts Dexcom's competitive advantages, and contends that there is additional headline risk vis-a-vis Medtronic' (MDT) Guardian Connect CGM approval in the pipeline. Further, Kalia believes Dexcom's stock is bound to be under pressure over the next 12-18 months.

DXCM

DexCom

$58.08

0.09 (0.16%)

ABT

Abbott

$59.19

0.27 (0.46%)

MDT

Medtronic

$83.97

0.05 (0.06%)

  • 04

    Jan

  • 24

    Jan

  • 26

    Feb

DXCM DexCom
$58.08

0.09 (0.16%)

01/04/18
PIPR
01/04/18
NO CHANGE
PIPR
Dexcom pullback a buying opportunity for longer-term investors, says Piper
Piper Jaffray analyst JP McKim believes Abbott's (ABT) Medicare approval for Libre is "more market-expanding than share-taking" for Dexcom (DXCM), and maintained an Overweight rating on Dexcom shares, seeing the pullback as a buying opportunity for longer-term investors. Dexcom shares are down 8.75% to $53 in late morning trading.
01/04/18
NORL
01/04/18
DOWNGRADE
NORL
Underperform
Dexcom downgraded to Underperform from Market Perform at Northland
12/27/17
PIPR
12/27/17
NO CHANGE
Target $60
PIPR
Overweight
Dexcom can beat Q4 estimates, guidance uncertain, says Piper Jaffray
Piper Jaffray analyst JP McKim believes Dexcom (DXCM) can beat Q4 numbers but he does not have conviction on how management will guide for 2018. His recent channel checks indicate the company has figured out the Medicare processes but that Abbott's (ABT) Libre is gaining "notable adoption" in the type 2 diabetes market. Checks indicate Dexcom has "cracked the Medicare code" in terms of training, billing and getting patients successfully through the pipeline, McKim tells investors in a research note. The analyst, however, expects more headline volatility for the shares around the Libre launch. He continues to recommend investors with a time horizon beyond a year buy the stock. The analyst keeps an Overweight rating on Dexcom with a $60 price target.
12/21/17
JEFF
12/21/17
NO CHANGE
JEFF
Jefferies lays out top 2018 ideas in Medical Supplies & Devices
Jefferies analyst Raj Denhoy calls Haemonetics (HAE), AxoGen (AXGN), Abbott (ABT) and Hologic (HOLX) his top Medical Supplies & Devices ideas to start 2018. Following a year of strong device performance in 2017, the analyst believes 2018 is "looking like more of the same." Denhoy raised his price target for Abiomed (ABMD) to $220, for Dexcom (DXCM) to $70, for Haemonetics to $68, for Hologic to $52, for LivaNova (LIVN) to $94, for Varex Imaging (VREX) to $44 and for Zimmer Biomet (ZBH) to $140. The analyst has Buy ratings on all of those stocks.
ABT Abbott
$59.19

0.27 (0.46%)

01/03/18
EVER
01/03/18
INITIATION
Target $64
EVER
Outperform
Abbott initiated with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Kumar started Abbott Laboratories with an Outperform rating and $64 price target. The analyst sees more room for shares to run in 2018 as the company's sales growth accelerates to the 5%-6% range.
01/04/18
LEHM
01/04/18
UPGRADE
Target $135
LEHM
Overweight
Edwards Lifesciences upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Matthew Taylor upgraded Edwards Lifesciences (EW) to Overweight and raised his price target for the shares to $135 from $125. The company can "bridge risks in 2018 to exciting growth drivers in 2019," Taylor tells investors in a research note. The analyst's top pick in U.S. Medical Supplies & Devices remains Abbott (ABT).
01/02/18
01/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. L Brands (LB) upgraded to Outperform from Neutral at Baird with analyst Mark Altschwagern saying he believes the company is on track to meet or exceed December comparable sales and fourth quarter expectations. 2. Lennar (LEN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Stephen East citing his post-tax reform earnings per share estimate but without the CalAtlantic (CAA) acquisition included. 3. Disney (DIS), Netflix (NFLX), AMC Networks (AMCX), and Discovery (DISCA) were upgraded to Outperform from Neutral at Macquarie. 4. Abbott (ABT) was upgraded to Overweight from Equal Weight at Morgan Stanley and to Overweight from Neutral at JPMorgan. 5. Baxter (BAX) was upgraded to Buy from Neutral at BofA/Merrill and to Overweight from Neutral at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MDT Medtronic
$83.97

0.05 (0.06%)

12/15/17
PIPR
12/15/17
NO CHANGE
Target $90
PIPR
Overweight
NuVasive's new lateral ALIF system underappreciated, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien views NuVasive's new lateral anterior lumbar interbody fusion procedure as an underappreciated revenue driver for the company. This as an important introduction for NuVasive as it finally allows the company to access the lower lumbar region with less invasiveness, O'Brien tells investors in a research note. He notes the product will allow NuVasive to compete head-to-head with Medtronic's (MDT) OLIF procedure, which he believes has grown quickly. O'Brien sees the lateral ALIF system adding $30M-$50M to NuVasive sales over the next three to four years, helping to push the stock higher. He keeps an Overweight rating on the stock with a $90 price target.
01/03/18
EVER
01/03/18
INITIATION
Target $92.5
EVER
Outperform
Medtronic initiated with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Kumar started Medtronic with an Outperform rating and $92.50 price target. The analyst has confidence in the company's revenue growth accelerating in the second half of 2018. He finds the stock "compelling" at current share levels.
01/02/18
BOFA
01/02/18
UPGRADE
BOFA
Buy
Medtronic upgraded to Buy from Neutral at BofA/Merrill
01/02/18
BOFA
01/02/18
UPGRADE
BOFA
Buy
Medtronic upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded Medtronic to Buy from Neutral and increased its price target to $94 from $90. Analyst Bob Hopkins believes Medtronic is on the "verge" of delivering more consistent growth driven by its pipeline and manufacturing footprint reduction, which should drive multiple expansion.

TODAY'S FREE FLY STORIES

DHI

D.R. Horton

$44.28

0.77 (1.77%)

13:10
08/14/18
08/14
13:10
08/14/18
13:10
Options
Size block of calls sold in D R Horton looks closing »

Size block of calls sold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$41.80

1.72 (4.29%)

, PFGC

Performance Food Group

$38.05

1.15 (3.12%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$41.80

1.72 (4.29%)

PFGC

Performance Food Group

$38.05

1.15 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 17

    Sep

AIV

Aimco

$43.25

0.5 (1.17%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07
Conference/Events
Aimco management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

A

Agilent

$67.14

1.19 (1.80%)

, CREE

Cree

$49.96

-0.32 (-0.64%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07
Earnings
Notable companies reporting after market close »

Notable companies…

A

Agilent

$67.14

1.19 (1.80%)

CREE

Cree

$49.96

-0.32 (-0.64%)

VIAV

Viavi

$11.09

0.13 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 05

    Sep

  • 06

    Sep

  • 12

    Sep

KO

Coca-Cola

$45.93

0.11 (0.24%)

, PEP

PepsiCo

$112.80

-0.22 (-0.19%)

13:06
08/14/18
08/14
13:06
08/14/18
13:06
Hot Stocks
Coca-Cola's BodyArmor deal seen as negative for Pepsi, Keurig Dr Pepper »

In latest attempt to…

KO

Coca-Cola

$45.93

0.11 (0.24%)

PEP

PepsiCo

$112.80

-0.22 (-0.19%)

KDP

Keurig Dr Pepper

$23.61

-0.14 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$30.23

0.025 (0.08%)

, AKS

AK Steel

$4.20

-0.06 (-1.41%)

13:05
08/14/18
08/14
13:05
08/14/18
13:05
Periodicals
Canada near to imposing broad steel tariffs, Dow Jones says »

Canadian officials are…

X

U.S. Steel

$30.23

0.025 (0.08%)

AKS

AK Steel

$4.20

-0.06 (-1.41%)

NUE

Nucor

$63.53

0.4 (0.63%)

STLD

Steel Dynamics

$43.57

-0.1 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

IGT

International Game

$20.44

-0.12 (-0.58%)

13:05
08/14/18
08/14
13:05
08/14/18
13:05
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLI

Mack-Cali Realty

$19.99

0.92 (4.82%)

13:03
08/14/18
08/14
13:03
08/14/18
13:03
Periodicals
Land & Buildings likely to push for Mack-Cali sale, Bloomberg reports »

Jonathan Litt's Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$356.33

0.29 (0.08%)

, GS

Goldman Sachs

$229.95

3.12 (1.38%)

12:56
08/14/18
08/14
12:56
08/14/18
12:56
Periodicals
Goldman not hired officially by Tesla at time of tweet, Bloomberg reports »

Goldman Sachs had not…

TSLA

Tesla

$356.33

0.29 (0.08%)

GS

Goldman Sachs

$229.95

3.12 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

DOMO

Domo

$18.38

-0.1 (-0.54%)

12:53
08/14/18
08/14
12:53
08/14/18
12:53
Hot Stocks
Breaking Hot Stocks news story on Domo »

Joshua G. James reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$90.91

1.25 (1.39%)

12:50
08/14/18
08/14
12:50
08/14/18
12:50
Options
8.8K Walmart Sep 92.5 - Oct 95 call spreads bought for 29c »

8.8K Walmart Sep 92.5 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMZN

Amazon.com

$1,916.80

21.29 (1.12%)

12:49
08/14/18
08/14
12:49
08/14/18
12:49
Periodicals
U.K's ASA says Amazon Prime's one-day claim misled customers, CNBC reports »

The U.K.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 13

    Sep

CCXI

ChemoCentryx

$11.12

-1.54 (-12.16%)

12:47
08/14/18
08/14
12:47
08/14/18
12:47
Recommendations
ChemoCentryx analyst commentary  »

ChemoCentryx selloff on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$28.00

0.66 (2.41%)

12:45
08/14/18
08/14
12:45
08/14/18
12:45
Options
American Eagle call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

12:40
08/14/18
08/14
12:40
08/14/18
12:40
General news
U.S. equities are extending their rebound »

U.S. equities are…

GOOG

Alphabet

$1,240.12

5.02 (0.41%)

, GOOGL

Alphabet Class A

$1,255.80

7.04 (0.56%)

12:38
08/14/18
08/14
12:38
08/14/18
12:38
Periodicals
Alphabet invests $375M in Obamacare startup Oscar, Bloomberg reports »

Alphabet is investing…

GOOG

Alphabet

$1,240.12

5.02 (0.41%)

GOOGL

Alphabet Class A

$1,255.80

7.04 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 22

    Aug

  • 18

    Sep

  • 28

    Oct

STXB

Spirit of Texas Bancshares

$21.48

(0.00%)

12:37
08/14/18
08/14
12:37
08/14/18
12:37
Hot Stocks
Breaking Hot Stocks news story on Spirit of Texas Bancshares »

FJ Capital reports 5.21%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EKSO

Ekso Bionics

$2.84

0.16 (5.97%)

12:35
08/14/18
08/14
12:35
08/14/18
12:35
Hot Stocks
Ekso Bionics awarded $5M Department of Veterans Affairs contract 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
08/14/18
08/14
12:35
08/14/18
12:35
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

ATVI

Activision Blizzard

$71.54

1.02 (1.45%)

, EA

Electronic Arts

$131.76

0.47 (0.36%)

12:32
08/14/18
08/14
12:32
08/14/18
12:32
Hot Stocks
Game On: 'Fortnite' reportedly poses malware risk on Android »

Welcome to "Game…

ATVI

Activision Blizzard

$71.54

1.02 (1.45%)

EA

Electronic Arts

$131.76

0.47 (0.36%)

GOOG

Alphabet

$1,239.50

4.4 (0.36%)

GOOGL

Alphabet Class A

$1,255.19

6.43 (0.51%)

SSNLF

Samsung

$0.00

(0.00%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$112.93

0.82 (0.73%)

CCOEY

Capcom

$0.00

(0.00%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 22

    Aug

  • 04

    Sep

  • 10

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 28

    Oct

URBN

Urban Outfitters

$47.93

0.51 (1.08%)

12:30
08/14/18
08/14
12:30
08/14/18
12:30
Options
Put spreads in Urban Outfitters ahead of earnings next week »

Put spreads in Urban…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

YUMC

Yum China

$35.81

1.59 (4.65%)

12:25
08/14/18
08/14
12:25
08/14/18
12:25
Options
Yum China call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

ACRS

Aclaris Therapeutics

$16.86

-0.27 (-1.58%)

12:25
08/14/18
08/14
12:25
08/14/18
12:25
Conference/Events
Cantor consumer products analysts to hold analyst/industry conference call »

Analysts, along with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

CLI

Mack-Cali Realty

$19.42

0.35 (1.84%)

12:22
08/14/18
08/14
12:22
08/14/18
12:22
Periodicals
Breaking Periodicals news story on Mack-Cali Realty »

Activist investor Litt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANSS

Ansys

$172.90

1.87 (1.09%)

12:22
08/14/18
08/14
12:22
08/14/18
12:22
Recommendations
Ansys analyst commentary  »

Ansys price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.